{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:46:24Z","timestamp":1782308784956,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Agence R\u00e9gionale de Sant\u00e9 Pays de Loire"},{"name":"Universit\u00e9 d'Angers"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13346-026-02091-z","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:21:15Z","timestamp":1775654475000},"page":"2488-2498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microfluidic ocular formulation of voriconazole designed for hospital production"],"prefix":"10.1007","volume":"16","author":[{"given":"Louise","family":"Stinat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Gimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gastebois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bienvenue","family":"Razafimandimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Tireau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Lautram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dallerac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Verron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Calvignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Crauste-Manciet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-0673","authenticated-orcid":false,"given":"Frederic","family":"Lagarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2091_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jfo.2017.05.013","volume":"40","author":"T Bourcier","year":"2017","unstructured":"Bourcier T, Sauer A, Dory A, et al. K\u00e9ratites fongiques. J Fr Ophtalmol. 2017;40:882\u20138.","journal-title":"J Fr Ophtalmol"},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","volume":"24","author":"N Sharma","year":"2022","unstructured":"Sharma N, Bagga B, Singhal D, et al. Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes. Ocul Surf. 2022;24:22\u201330.","journal-title":"Ocul Surf"},{"key":"2091_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090786","volume":"12","author":"P Chennell","year":"2020","unstructured":"Chennell P, Yessaad M, Abd El Kader F, et al. Do ophthalmic solutions of amphotericin B solubilised in 2-hydroxypropyl-\u03b3-cyclodextrins possess an extended physicochemical stability? Pharmaceutics. 2020;12: 786.","journal-title":"Pharmaceutics"},{"key":"2091_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1128\/AAC.01126-08","volume":"53","author":"A Dupuis","year":"2009","unstructured":"Dupuis A, Tournier N, Le Moal G, et al. Preparation and stability of voriconazole eye drop solution. Antimicrob Agents Chemother. 2009;53:798\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2091_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/OPTH.S447138","volume":"18","author":"R Awad","year":"2024","unstructured":"Awad R, Ghaith AA, Awad K, et al. Fungal Keratitis: diagnosis, management, and recent advances. Clin Ophthalmol Auckl NZ. 2024;18:85\u2013106.","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"2091_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/jphp.13265","volume":"72","author":"BNV Rasoanirina","year":"2020","unstructured":"Rasoanirina BNV, Lassoued MA, Miladi K, et al. Self-nanoemulsifying drug delivery system to improve transcorneal permeability of voriconazole: in-vivo studies. J Pharm Pharmacol. 2020;72:889\u201396.","journal-title":"J Pharm Pharmacol"},{"key":"2091_CR7","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770.","journal-title":"Adv Drug Deliv Rev"},{"key":"2091_CR8","doi-asserted-by":"publisher","first-page":"115006","DOI":"10.1016\/j.addr.2023.115006","volume":"200","author":"X Wang","year":"2023","unstructured":"Wang X, Luan F, Yue H, et al. Recent advances of smart materials for ocular drug delivery. Adv Drug Deliv Rev. 2023;200:115006.","journal-title":"Adv Drug Deliv Rev"},{"key":"2091_CR9","doi-asserted-by":"publisher","first-page":"115113","DOI":"10.1016\/j.addr.2023.115113","volume":"202","author":"J Ji","year":"2023","unstructured":"Ji J, Tao Y, Pang Y. Editorial: ocular drug delivery - challenges, opportunities, and developments. Adv Drug Deliv Rev. 2023;202:115113.","journal-title":"Adv Drug Deliv Rev"},{"key":"2091_CR10","doi-asserted-by":"publisher","unstructured":"Ismail A, Nasr M, Sammour O. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic\/pharmacodynamic properties. Int J Pharm. 583.  https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119402.","DOI":"10.1016\/j.ijpharm.2020.119402"},{"key":"2091_CR11","doi-asserted-by":"publisher","unstructured":"Mehrandish S, Mirzaeei S. Design of Novel Nanoemulsion Formulations for Topical Ocular Delivery of Itraconazole: Development, Characterization and In Vitro Bioassay. Adv Pharm Bull. 12.  https:\/\/doi.org\/10.34172\/apb.2022.009.","DOI":"10.34172\/apb.2022.009"},{"key":"2091_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","volume":"252","author":"Y Singh","year":"2017","unstructured":"Singh Y, Meher JG, Raval K, et al. Nanoemulsion: concepts, development and applications in drug delivery. J Controlled Release. 2017;252:28\u201349.","journal-title":"J Controlled Release"},{"key":"2091_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ijpharm.2017.10.017","volume":"534","author":"G Lefebvre","year":"2017","unstructured":"Lefebvre G, Riou J, Bastiat G, et al. Spontaneous nano-emulsification: process optimization and modeling for the prediction of the nanoemulsion\u2019s size and polydispersity. Int J Pharm. 2017;534:220\u20138.","journal-title":"Int J Pharm"},{"key":"2091_CR14","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.1039\/D1NR00879J","volume":"13","author":"N Rolley","year":"2021","unstructured":"Rolley N, Bonnin M, Lefebvre G, et al. Galenic lab-on-a-chip concept for lipid nanocapsules production. Nanoscale. 2021;13:11899\u2013912.","journal-title":"Nanoscale"},{"key":"2091_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ces.2016.10.025","volume":"169","author":"K Wang","year":"2017","unstructured":"Wang K, Luo G. Microflow extraction: a review of recent development. Chem Eng Sci. 2017;169:18\u201333.","journal-title":"Chem Eng Sci"},{"key":"2091_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1039\/C5LC01159K","volume":"16","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yan S, Yuan D, et al. Fundamentals and applications of inertial microfluidics: a review. Lab Chip. 2015;16:10\u201334.","journal-title":"Lab Chip"},{"key":"2091_CR17","doi-asserted-by":"publisher","unstructured":"Viktorov V, Mahmud MdR, Visconte C. Design and Characterization of a New H-C Passive Micromixer up to Reynolds Number 100. Chem Eng Res Des. 108. https:\/\/doi.org\/10.1016\/j.cherd.2015.12.005.","DOI":"10.1016\/j.cherd.2015.12.005"},{"key":"2091_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.nantod.2016.10.006","volume":"11","author":"M Lu","year":"2016","unstructured":"Lu M, Ozcelik A, Grigsby CL, et al. Microfluidic hydrodynamic focusing for synthesis of nanomaterials. Nano Today. 2016;11:778\u201392.","journal-title":"Nano Today"},{"key":"2091_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1039\/D3LC00821E","volume":"24","author":"S Mehraji","year":"2024","unstructured":"Mehraji S, DeVoe DL. Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities. Lab Chip. 2024;24:1154\u201374.","journal-title":"Lab Chip"},{"key":"2091_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.colsurfb.2014.02.007","volume":"117","author":"R Kumar","year":"2014","unstructured":"Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces. 2014;117:82\u20138.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2091_CR21","first-page":"611","volume":"8","author":"E Sigward","year":"2013","unstructured":"Sigward E, Mignet N, Rat P, et al. Formulation and cytotoxicity evaluation of new self-emulsifying multiple W\/O\/W nanoemulsions. Int J Nanomedicine. 2013;8:611\u201325.","journal-title":"Int J Nanomedicine"},{"key":"2091_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/10717540903126165","volume":"16","author":"Z Liu","year":"2009","unstructured":"Liu Z, Zhang X, Li J, et al. Effects of Labrasol on the corneal drug delivery of baicalin. Drug Deliv. 2009;16:399\u2013404.","journal-title":"Drug Deliv"},{"key":"2091_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1442-9071.2004.00914.x","volume":"32","author":"SL Fialho","year":"2004","unstructured":"Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Experiment Ophthalmol. 2004;32:626\u201332.","journal-title":"Clin Experiment Ophthalmol"},{"key":"2091_CR24","volume-title":"Handbook of pharmaceutical excipients","author":"RC Rowe","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical press; 2009.","edition":"6"},{"key":"2091_CR25","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1167\/iovs.14-14700","volume":"55","author":"M Vicario-de-la-Torre","year":"2014","unstructured":"Vicario-de-la-Torre M, Ben\u00edtez-del-Castillo JM, Vico E, et al. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film. Invest Ophthalmol Vis Sci. 2014;55:7839\u201347.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2091_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ejpb.2014.12.015","volume":"94","author":"AC Braun","year":"2015","unstructured":"Braun AC, Ilko D, Merget B, et al. Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods. Eur J Pharm Biopharm. 2015;94:559\u201368.","journal-title":"Eur J Pharm Biopharm"},{"key":"2091_CR27","unstructured":"Voriconazole.  https:\/\/go.drugbank.com\/drugs\/DB00582.  Accessed 2 Sept 2024."},{"key":"2091_CR28","doi-asserted-by":"publisher","first-page":"120318","DOI":"10.1016\/j.ijpharm.2021.120318","volume":"597","author":"V D\u00edaz-Tom\u00e9","year":"2021","unstructured":"D\u00edaz-Tom\u00e9 V, Garc\u00eda-Otero X, Varela-Fern\u00e1ndez R, et al. In situ forming and mucoadhesive ophthalmic voriconazole\/HP\u03b2CD hydrogels for the treatment of fungal keratitis. Int J Pharm. 2021;597:120318.","journal-title":"Int J Pharm"},{"key":"2091_CR29","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/ijms24032343","volume":"24","author":"HMSH Soe","year":"2023","unstructured":"Soe HMSH, Kerdpol K, Rungrotmongkol T, et al. voriconazole eye drops: enhanced solubility and stability through ternary voriconazole\/sulfobutyl ether \u03b2-cyclodextrin\/polyvinyl alcohol complexes. Int J Mol Sci. 2023;24:2343.","journal-title":"Int J Mol Sci"},{"key":"2091_CR30","doi-asserted-by":"publisher","first-page":"123394","DOI":"10.1016\/j.ijpharm.2023.123394","volume":"645","author":"HMSH Soe","year":"2023","unstructured":"Soe HMSH, Junthip J, Chamni S, et al. A promising synthetic citric crosslinked \u03b2-cyclodextrin derivative for antifungal drugs: solubilization, cytotoxicity, and antifungal activity. Int J Pharm. 2023;645:123394.","journal-title":"Int J Pharm"},{"key":"2091_CR31","doi-asserted-by":"publisher","unstructured":"Permana AD, Utami RN, Layadi P, et al. Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis. Int J Pharm. 602.  https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120623.","DOI":"10.1016\/j.ijpharm.2021.120623"},{"key":"2091_CR32","doi-asserted-by":"publisher","first-page":"111445","DOI":"10.1016\/j.msec.2020.111445","volume":"119","author":"Y Wen","year":"2021","unstructured":"Wen Y, Jia H, Mo Z, et al. Cross-linked thermosensitive nanohydrogels for ocular drug delivery with a prolonged residence time and enhanced bioavailability. Mater Sci Eng C Mater Biol Appl. 2021;119:111445.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2091_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jconrel.2023.10.054","volume":"364","author":"E Roger","year":"2023","unstructured":"Roger E, Franconi F, Do TAT, et al. Evidence of residual micellar structures in a lipid nanocapsule dispersion. A multi-technique approach. J Control Release Off J Control Release Soc. 2023;364:700\u201317.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"2091_CR34","doi-asserted-by":"publisher","unstructured":"Al Khateb K, Ozhmukhametova EK, Mussin MN, et al. In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery. Int J Pharm. 502.  https:\/\/doi.org\/10.1016\/j.ijpharm.2016.02.027.","DOI":"10.1016\/j.ijpharm.2016.02.027"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02091-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02091-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02091-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:50:38Z","timestamp":1782305438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02091-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02091-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this study (no patients or animals involved).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not declare any conflict or competing interest, this study is totally independent from private pharmaceutical industry and has been performed by public staff belonging to the French University of Angers.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}